DK0641561T3 - Medicinsk anordning til indgivelse af aktive bestanddele eller medikamenter i meget lave doser, specielt homøopatiske medik - Google Patents

Medicinsk anordning til indgivelse af aktive bestanddele eller medikamenter i meget lave doser, specielt homøopatiske medik

Info

Publication number
DK0641561T3
DK0641561T3 DK94112012T DK94112012T DK0641561T3 DK 0641561 T3 DK0641561 T3 DK 0641561T3 DK 94112012 T DK94112012 T DK 94112012T DK 94112012 T DK94112012 T DK 94112012T DK 0641561 T3 DK0641561 T3 DK 0641561T3
Authority
DK
Denmark
Prior art keywords
drugs
administration
medical device
active ingredients
low doses
Prior art date
Application number
DK94112012T
Other languages
Danish (da)
English (en)
Inventor
Paolo Cavazza
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Application granted granted Critical
Publication of DK0641561T3 publication Critical patent/DK0641561T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94112012T 1993-09-02 1994-08-02 Medicinsk anordning til indgivelse af aktive bestanddele eller medikamenter i meget lave doser, specielt homøopatiske medik DK0641561T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM930591A IT1261849B (it) 1993-09-02 1993-09-02 Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.

Publications (1)

Publication Number Publication Date
DK0641561T3 true DK0641561T3 (da) 1999-07-26

Family

ID=11401933

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94112012T DK0641561T3 (da) 1993-09-02 1994-08-02 Medicinsk anordning til indgivelse af aktive bestanddele eller medikamenter i meget lave doser, specielt homøopatiske medik

Country Status (12)

Country Link
US (1) US5683712A (it)
EP (1) EP0641561B1 (it)
JP (1) JPH07165566A (it)
KR (1) KR950007808A (it)
AT (1) ATE173162T1 (it)
CA (1) CA2129760A1 (it)
DE (1) DE69414502T2 (it)
DK (1) DK0641561T3 (it)
ES (1) ES2125380T3 (it)
GR (1) GR3029308T3 (it)
IT (1) IT1261849B (it)
ZA (1) ZA946698B (it)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
GB2354636A (en) * 1999-09-25 2001-03-28 Ibm Mounting chips on substrates
FR2806910B1 (fr) * 2000-04-03 2003-01-24 Dolisos Lab Procede d'inactivation virale de solutions hydro-alcooliques
RU2181297C2 (ru) 2000-06-20 2002-04-20 Эпштейн Олег Ильич Способ лечения патологического синдрома и лекарственное средство
US20030022206A1 (en) * 2001-05-16 2003-01-30 Kay Robert A. Method of characterizing a homeopathic preparation
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
UA76641C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
UA76640C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб
UA76638C2 (en) * 2002-08-02 2006-08-15 Oleh Illich Epshtein Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76639C2 (uk) * 2002-08-02 2006-08-15 Олєг Ільіч Епштєйн Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
US20050255139A1 (en) * 2004-05-14 2005-11-17 Hurd Jonathan L Polymeric compositions with embedded pesticidal desiccants
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
KR102110379B1 (ko) 2005-12-01 2020-05-14 유니버시티 오브 메사츄세츠 로웰 보툴리눔 나노에멀젼
RU2309732C1 (ru) * 2006-03-13 2007-11-10 Олег Ильич Эпштейн Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
US8658391B2 (en) 2006-04-27 2014-02-25 Anterios, Inc. Assessment of the effects of topical administration of chemodenervating pharmaceuticals
BRPI0712540A2 (pt) * 2006-06-06 2012-10-16 Oleg Iliich Epshtein agente medicinal para tratar adiposidade, diabetes, e doenças associadas com intoleráncia a glicose
SG179457A1 (en) 2006-12-01 2012-04-27 Anterios Inc Peptide nanoparticles and uses therefor
SG177184A1 (en) 2006-12-01 2012-01-30 Anterios Inc Amphiphilic entity nanoparticles
US8940326B2 (en) 2007-03-19 2015-01-27 Vita Sciences Llc Transdermal patch and method for delivery of vitamin B12
CN101765423B (zh) 2007-05-31 2014-08-06 安特里奥公司 核酸纳米粒子和其用途
US20090047334A1 (en) * 2007-08-13 2009-02-19 Patricia Williams Transdermal patch for extended delivery of calcium
KR101848095B1 (ko) 2008-06-26 2018-04-11 안테리오스, 인코퍼레이티드 경피 운반
JP2013532181A (ja) 2010-07-15 2013-08-15 イリイチ・エプシテイン オレグ 組み合わせ医薬組成物及び胃腸管の機能的な疾患又は状態を治療する方法
EP2593474A2 (en) 2010-07-15 2013-05-22 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
PH12013500107A1 (en) 2010-07-15 2013-03-11 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
WO2012010238A1 (en) 2010-07-17 2012-01-26 Merck Patent Gmbh Enhancement of penetration and action
PH12013500142A1 (en) 2010-07-21 2013-03-11 Oleg Iliich Epshtein Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
EA029199B1 (ru) 2010-07-21 2018-02-28 Олег Ильич Эпштейн Комбинированная фармацевтическая композиция для лечения синдрома дефицита внимания и гиперактивности и способы лечения синдрома дефицита внимания и гиперактивности
US20120328549A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Oil compositions
BR112013018918A2 (pt) 2011-01-24 2016-10-04 Anterios Inc composições de nanopartículas
US20120328701A1 (en) 2011-01-24 2012-12-27 Anterios, Inc. Nanoparticle compositions, formulations thereof, and uses therefor
US20120225018A1 (en) * 2011-03-03 2012-09-06 Nancy Josephine Polich Homeopathic therapeutic method and compositions
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
US8497279B2 (en) 2011-03-10 2013-07-30 Rigel Pharmaceuticals, Inc. Treatment for discoid lupus
US9603898B2 (en) 2011-03-23 2017-03-28 Deseret Biologicals, Inc. Formulations of diluted amino acid segments and methods for making same
BE1020027A3 (fr) 2011-06-23 2013-04-02 Jean Pierre Mageren Compositions homeopathiques pour le traitement des douleurs du dos et des sciatiques.
US9597385B2 (en) 2012-04-23 2017-03-21 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
KR101365321B1 (ko) * 2012-05-22 2014-02-20 제일약품주식회사 매트릭스내 비스테로이드성 소염진통제의 농도구배를 이용하여 경피투과도를 향상시킨 패취제
JP2015528501A (ja) 2012-09-12 2015-09-28 ライジェル ファーマシューティカルズ， インコーポレイテッド 白斑の治療法
KR102233251B1 (ko) 2013-04-03 2021-03-26 엔-폴드 엘엘씨 신규 나노입자 조성물
AU2015252949B2 (en) 2014-05-01 2020-12-10 Anterios, Inc. Methods to treat, prevent, and improve skin conditions
BR112018001376A2 (pt) 2015-07-24 2018-09-11 Glaxo Group Ltd tratamento para vitiligo
MX2019005833A (es) 2016-11-21 2019-10-30 Eirion Therapeutics Inc Administracion transdermica de agentes grandes.
AU2018389104A1 (en) 2017-12-20 2020-07-30 Allergan, Inc. Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenation
KR20250161056A (ko) 2018-09-13 2025-11-14 에이리온 테라퓨틱스, 인코포레이티드 플라즈미노겐 활성인자 억제제 1 (pai-1) 억제제의 용도
KR20250163416A (ko) 2018-09-13 2025-11-20 에이리온 테라퓨틱스, 인코포레이티드 플라즈미노겐 활성인자 억제제 1 (pai-1) 억제제 및 이의 용도
MX2021006102A (es) 2018-12-03 2021-09-21 Eirion Therapeutics Inc Suministro mejorado de agentes grandes.
US20220296503A1 (en) 2019-05-14 2022-09-22 Eirion Therapeutics, Inc. Delaying peak effect and/or extending duration of response
WO2021003315A1 (en) 2019-07-02 2021-01-07 Rowley Clifford T Transdermal patch providing improved permeability
US20230125585A1 (en) 2019-08-02 2023-04-27 Enterin, Inc. Dosing protocols and regimens for aminosterol treatment
AU2024344613A1 (en) 2023-09-18 2026-04-23 Eirion Therapeutics, Inc. Topical compositions and uses of pai-1 inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060084A (en) * 1976-09-07 1977-11-29 Alza Corporation Method and therapeutic system for providing chemotherapy transdermally
US4605548A (en) * 1983-05-31 1986-08-12 Nitto Electric Industrial Co., Ltd. Drug administration material
US4788064A (en) * 1987-07-31 1988-11-29 Warner-Lambert Company Transdermal delivery system
WO1992006701A1 (en) * 1990-10-18 1992-04-30 Huffstutler, M., Conrad, Jr. Preparation of concentrated fluid symphytum extracts, therapeutic forms and methods of use

Also Published As

Publication number Publication date
ZA946698B (en) 1995-05-02
CA2129760A1 (en) 1995-03-03
US5683712A (en) 1997-11-04
DE69414502D1 (de) 1998-12-17
KR950007808A (ko) 1995-04-15
EP0641561A3 (en) 1995-09-27
ITRM930591A1 (it) 1995-03-02
ATE173162T1 (de) 1998-11-15
JPH07165566A (ja) 1995-06-27
IT1261849B (it) 1996-06-03
DE69414502T2 (de) 1999-04-08
ITRM930591A0 (it) 1993-09-02
EP0641561A2 (en) 1995-03-08
ES2125380T3 (es) 1999-03-01
GR3029308T3 (en) 1999-05-28
EP0641561B1 (en) 1998-11-11

Similar Documents

Publication Publication Date Title
DK0641561T3 (da) Medicinsk anordning til indgivelse af aktive bestanddele eller medikamenter i meget lave doser, specielt homøopatiske medik
DE69327628D1 (de) Transdermales arzneimittelverabreichungssystem
DE69121881D1 (de) Hautelektrodenaufbau und dazugehöriges gerät zur transdermalen verabreichung von heilmitteln
DK0831827T3 (da) Nye formuleringer til transdermal levering af pergolid
ES2023649B3 (es) Formas de dosificacion y administracion para medicamentos, reactivos o similares asi como procedimiento para su obtencion.
DE3676235D1 (de) Arzneizubereitung mit verzoegerter wirkstoffabgabe.
DE3879853D1 (de) Klebstoffzusammensetzung, zusammensetzung mit kontrollierter wirkstofffreisetzung und system zur transdermalen anwendung von arzneien.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DK0922453T3 (da) Tulobuterolholdigt præparat til perkutan absorption
DK567088A (da) Indretning til transdermal laegemiddelindgift
ES2060593T3 (es) Sistema de aporte de farmacos.
DE69918310D1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
KR900015761A (ko) 경피성 단일체 시스템
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
ES2067250T3 (es) Preparado farmaceutico sin disolventes para administracion oral, con liberacion retardada de la sustancia activa y procedimiento para su fabricacion.
ES2016620B3 (es) Sistema para liberar medicamentos con bioaceptabilidad mejorada.
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
DK0460622T3 (da) Lægemiddelpræparat til systemisk behandling af pryd- og nyttefisk
SE9301877D0 (sv) In situ gel for therapeutic use
DK649487A (da) Praeparat til afgivelse af et topisk laegemiddel
DE3772954D1 (de) Arzneimittel mit verzoegerter wirkstoffabgabe.
BR9808876A (pt) Sistema de liberação de medicamento
NO155620C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzo(a,d)-cyklohepten-derivater.